PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy in patients with stage III, locally advanced, unresectable NSCLC

de Wit, M. and Laack, E. and Schulz, C. and Wolff, T. and Rueckert, A. and Reck, M. and Faehling, M. and Fischer, J. (2018) PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy in patients with stage III, locally advanced, unresectable NSCLC. STRAHLENTHERAPIE UND ONKOLOGIE, 194 (Suppl1). S24. ISSN 0179-7158, 1439-099X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Petra Gürster
Date Deposited: 02 Jul 2020 05:24
Last Modified: 02 Jul 2020 05:24
URI: https://pred.uni-regensburg.de/id/eprint/14470

Actions (login required)

View Item View Item